Total investments 14
Average round size 
$42M
The average size of a deal this fund participated in
Portfolio companies 7
Lead investments 3
Follow on index
0.50How often the fund supports its portfolio startups at next rounds
Exits 6
Key employees 1
New York, New York, United States Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Caxton Advantage Life Sciences Fund:
Typical Co-investors
Caxton Advantage Life Sciences Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Caxton Advantage Life Sciences Fund:
There are no funds here. If we find new data, we will add it here.
Funds with similar focus
Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Azure | Redmond, United States, Washington |
| Bright Success Capital | China, Hong Kong, Hong Kong Island |
| DT&I | - |
| FamilySearch | Salt Lake City, United States, Utah |
| Five Seasons Ventures | France, Ile-de-France, Paris |
| InnoSpring Seed Fund | California, Palo Alto, United States |
| K2 Investment Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| KP Engineering | Texas, Tyler, United States |
| LongeVC | Lugano, Switzerland, Ticino |
| RCM Business | Bhilwara, India, Rajasthan |
| Riceland HealthCare | Texas, United States, Winnie |
| Sarissa Capital Management | - |
| Singh Capital Partners | Maryland, Potomac, United States |
| TechnoStart | Germany, Ludwigsburg, Mecklenburg-Vorpommern |
| TF1 Group | Boulogne, France, Nord-Pas-de-Calais |
| The Westly Group | California, Menlo Park, United States |
| Travel Capitalist Ventures (USA, S Africa, Mideast, India) | California, Irvine, United States |
| UHT Investments | Dubai, United Arab Emirates |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Gemin X Pharmaceuticals | $38M | 03 Jul 2008 | Montreal, Quebec, Canada | ||
Corthera | $23M | 20 Dec 2007 | California, United States | ||
Mevion Medical Systems | $6M | 08 Oct 2007 | Massachusetts, United States | ||
Regado Biosciences | $23M | 27 Mar 2007 | Durham, North Carolina, United States |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent Caxton Advantage Life Sciences Fund?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 14
Average round size 42M
Peak activity year 2009
Lead investments 3
Follow on index 0.50
Exits 6
Group Appearance index 1.00
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Gemin X Pharmaceuticals | $38M | 03 Jul 2008 | Montreal, Quebec, Canada | ||
Corthera | $23M | 20 Dec 2007 | California, United States | ||
Mevion Medical Systems | $6M | 08 Oct 2007 | Massachusetts, United States | ||
Regado Biosciences | $23M | 27 Mar 2007 | Durham, North Carolina, United States |
